Inventor · disambiguated record
Erkan Baloglu
Also filed as: BALOGLU ERKAN
36 granted patents·14 pending applications·519 citations·filing 2001–2022
98Inventor score
Files withKARYOPHARM THERAPEUTICS INC25BIOGEN MA INC6BALOGLU ERKAN5IMMUNOGEN INC5INOTEK PHARMACEUTICALS CORP3
Top patents by PatentIndex Score
50 records- 0197US10335393B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·20 cites·12 claims
- 0297US10058535B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Aug 28, 2018·24 cites·1 claims
- 0397US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 0497US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 0597US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 0697US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 0795US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 0895US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 0995US7186851B2Facile method for synthesizing baccatin III compoundsIMMUNOGEN INC·Filed 2005·Granted Mar 6, 2007·23 cites·69 claims
- 1094US10722497B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2019·Granted Jul 28, 2020·3 cites·26 claims
- 1194US10709706B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 14, 2020·11 cites·34 claims
- 1294US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 1393US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 1493US7414073B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2004·Granted Aug 19, 2008·42 cites·57 claims
- 1592US10617677B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2018·Granted Apr 14, 2020·3 cites·18 claims
- 1692US10202366B2Methods of promoting wound healing using CRM1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Feb 12, 2019·22 cites·6 claims
- 1791US10526295B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·12 cites·20 claims
- 1891US7667054B2Cytotoxic agents comprising new taxanesAVENTIS PHARMA SA·Filed 2005·Granted Feb 23, 2010·20 cites·48 claims
- 1991US7598290B2Cytotoxic agents comprising new C-2 modified taxanesIMMUNOGEN INC·Filed 2007·Granted Oct 6, 2009·20 cites·45 claims
- 2090US6828319B2Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·34 cites·131 claims
- 2189US8981084B2Oxadiazole HDAC inhibitorsBALOGLU ERKAN·Filed 2011·Granted Mar 17, 2015·19 cites·7 claims
- 2288US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2387US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 2487US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 2586US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 2686US6956035B2Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Oct 18, 2005·19 cites·22 claims
- 2785US10925859B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2020·Granted Feb 23, 2021·1 cites·21 claims
- 2885US10363247B2(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancerKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 30, 2019·5 cites·15 claims
- 2983US8901156B2Compounds and methodsBALOGLU ERKAN·Filed 2011·Granted Dec 2, 2014·8 cites·22 claims
- 3082US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3182US7495114B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2004·Granted Feb 24, 2009·10 cites·38 claims
- 3278US11318120B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2021·Granted May 3, 2022·0 cites·6 claims
- 3376US7390898B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2003·Granted Jun 24, 2008·9 cites·131 claims
- 3474US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 3570US10858347B2Multicyclic compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Dec 8, 2020·1 cites·31 claims
- 3659US2008262016A1Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 3758US12318386B2Combination of XPO1 inhibitors and second agents for the treatment of prostate cancerKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 3, 2025·0 cites·8 claims
- 3858US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3953US2015038534A1Compounds and methodsTEMPERO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4050US2003096833A1Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereofFiled 2001·Application pending·0 cites
- 4143US2014256740A1Compounds and methodsTEMPERO PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4241US2014315881A1Compounds and methodsTEMPERO PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4341US2014155419A1Compounds and methodsBALOGLU ERKAN·Filed 2012·Application pending·0 cites
- 4439US2014155381A1Compounds and methodsBALOGLU ERKAN·Filed 2012·Application pending·0 cites
- 4539US2005228007A1Isoquinoline derivatives and methods of use thereofJAGTAP PRAKASH·Filed 2005·Application pending·0 cites
- 4638US2019218207A13-(Pyridin-3-yl)-Acrylamide and N-(Pyridin-3-yl)-Acrylamide Derivatives and Their Use as PAK or NAMPT ModulatorsKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4738US2019002448A1Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4837US2018244660A1Cyclopropylderivatives and their use as kinase inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4936US2017369470A1Cyclic Compounds and Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 5036US2012322827A1Compounds and methodsBALOGLU ERKAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erkan Baloglu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →